SUZ Stock Analysis: Suzano Papel e Celulose | NYSE
Paper & Paper Products | NYSE, USA | Market Cap: 11.873m USD | 12M Return: 8.1% | US86959K1051 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 36.7M
Qual. Beats: 0
Rev. Trend: 85.9%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.8 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Suzano S.A., listed on the NYSE under the ticker SUZ, is a Brazilian manufacturer of pulp and paper products with operations both domestically and internationally. The company operates through two main segments: Cellulose and Paper, offering a diverse range of products including coated and uncoated printing and writing papers, paperboards, tissue papers, and market and fluff pulps. Beyond its core manufacturing activities, Suzano is involved in a broad array of businesses, such as biofuel research and production, port terminal operations, power generation, and the development of biotechnology and nanocrystalline pulps. The company also explores cellulose-based innovations, including fibers, yarns, textile filaments, and lignin research, reflecting its commitment to expanding the applications of its core materials. Founded in 1924 and headquartered in Salvador, Brazil, Suzano was previously known as Suzano Papel e Celulose S.A. before rebranding in April 2019. As a large-cap company in the Materials sector, specifically within the Paper Products sub-industry, Suzano plays a significant role in the global pulp and paper market.
- Eucalyptus pulp prices surge on constrained global supply
- Brazilian real weakness lifts dollar-denominated export revenue margins
- Cerrado project ramp-up expands market pulp capacity by millions of tonnes
| Net Income: 8.36b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -0.22 > 1.0 |
| NWC/Revenue: 55.45% < 20% (prev 57.16%; Δ -1.71% < -1%) |
| CFO/TA 0.09 > 3% & CFO 16.9b > Net Income 8.36b |
| Net Debt (90.9b) to EBITDA (29.7b): 3.06 < 3 |
| Current Ratio: 2.54 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.23b) vs 12m ago -0.35% < -2% |
| Gross Margin: 26.04% > 18% (prev 34.44%; Δ -8.40% > 0.5%) |
| Asset Turnover: 29.66% > 50% (prev 31.13%; Δ -1.47% > 0%) |
| Interest Coverage Ratio: 2.50 > 6 (EBIT TTM 17.0b / Interest Expense TTM 6.82b) |
| A: 0.15 (Total Current Assets 48.2b - Total Current Liabilities 19.0b) / Total Assets 191b |
| B: 0.04 (Retained Earnings 8.28b / Total Assets 191b) |
| C: 0.10 (EBIT TTM 17.0b / Avg Total Assets 178b) |
| D: 0.39 (Book Value of Equity 51.6b / Total Liabilities 133b) |
| Altman-Z'' = 2.20 = BBB |
| DSRI: 1.66 (Receivables 10.5b/6.13b, Revenue 52.7b/51.2b) |
| GMI: 1.32 (GM 34.44% / 26.04%) |
| AQI: 1.02 (AQ_t 0.32 / AQ_t-1 0.32) |
| SGI: 1.03 (Revenue 52.7b / 51.2b) |
| TATA: -0.05 (NI 8.36b - CFO 16.9b) / TA 191b) |
| Beneish M = -2.16 (Cap -4..+1) = BB |
As of November 17, 2026, the stock is trading at USD 9.59 with a total of 3,494,132 shares traded. Over the past week, the price has changed by -1.94%, over one month by +12.82%, over three months by +22.01% and over the past year by +8.07%.
Current recommended Stop Loss: 9.20 (which is 4.1% or 1.6 ATR below the current price).
Suzano Papel e Celulose has received a consensus analysts rating of 4.67. Therefore, it is recommended to buy SUZ.
- StrongBuy: 4
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 12 | 25.3% |
Market Cap BRL = 68.7b (11.9b USD * 5.78385 USD.BRL)
P/E Trailing = 7.5984
P/E Forward = 8.9366
P/S = 0.2275
P/B = 1.3071
Revenue TTM = 52.7b BRL
EBIT TTM = 17.0b BRL
EBITDA TTM = 29.7b BRL
Long Term Debt = 93.2b BRL (from longTermDebt, last quarter)
Short Term Debt = 5.61b BRL (from shortTermDebt, last quarter)
Debt = 112b BRL (from shortLongTermDebtTotal, last quarter) + Leases 7.13b
Net Debt = 90.9b BRL (calculated: Debt 112b - CCE 21.2b)
Enterprise Value = 160b BRL (68.7b + Debt 112b - CCE 21.2b)
Interest Coverage Ratio = 2.50 (Ebit TTM 17.0b / Interest Expense TTM 6.82b)
EV/FCF = 27.26x (Enterprise Value 160b / FCF TTM 5.85b)
FCF Yield = 3.67% (FCF TTM 5.85b / Enterprise Value 160b)
FCF Margin = 11.12% (FCF TTM 5.85b / Revenue TTM 52.7b)
Net Margin = 15.88% (Net Income TTM 8.36b / Revenue TTM 52.7b)
Gross Margin = 26.04% ((Revenue TTM 52.7b - Cost of Revenue TTM 38.9b) / Revenue TTM)
Gross Margin QoQ = 23.72% (prev 22.87%)
Tobins Q-Ratio = 0.84 (Enterprise Value 160b / Total Assets 191b)
Interest Expense / Debt = 6.08% (Interest Expense 6.82b / Debt 112b)
Taxrate = 31.00% (3.76b / 12.1b)
NOPAT = 11.8b (EBIT 17.0b * (1 - 31.00%))
Current Ratio = 2.54 (Total Current Assets 48.2b / Total Current Liabilities 19.0b)
Debt / Equity = 2.17 (Debt 112b / totalStockholderEquity, last quarter 51.6b)
Debt / EBITDA = 3.06 (Net Debt 90.9b / EBITDA 29.7b)
Debt / FCF = 15.53 (Net Debt 90.9b / FCF TTM 5.85b)
Total Stockholder Equity = 48.3b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.71% (Net Income 8.36b / Total Assets 191b)
RoE = 17.32% (Net Income TTM 8.36b / Total Stockholder Equity 48.3b)
RoCE = 12.04% (EBIT 17.0b / Capital Employed (Equity 48.3b + L.T.Debt 93.2b))
RoIC = 6.73% (NOPAT 11.8b / Invested Capital 175b)
WACC = 5.43% (E(68.7b)/V(181b) * Re(7.44%) + D(112b)/V(181b) * Rd(6.08%) * (1-Tc(0.31)))
Discount Rate = 7.44% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -68.22 | Cagr: -1.70%
[DCF] Terminal Value 76.46% ; FCFF base≈5.68b ; Y1≈6.09b ; Y5≈7.36b
[DCF] Fair Price = 17.90 (EV 113b - Net Debt 90.9b = Equity 22.0b / Shares 1.23b; r=8.35% [WACC [floored]]; 5y FCF grow 8.24% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.12 | # QB: 0
Revenue Correlation: 85.90 | Revenue CAGR: 12.56% | SUE: -0.40 | # QB: 0
EPS current Quarter (2027-03-31): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS current Year (2026-12-31): EPS=1.88 | Chg30d=+9.46% | Revisions=+25% | GrowthEPS=-9.8% | GrowthRev=+15.7%
EPS next Year (2027-12-31): EPS=1.09 | Chg30d=-2.76% | Revisions=-25% | GrowthEPS=-41.8% | GrowthRev=+12.6%